Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospe | AcademicGPT, tlooto

The association of high tissue TMB (tTMB-high) with outcomes in ten tumour-type-specific cohorts from the phase 2 KEYNOTE-158 study, which assessed the anti-PD-1 monoclonal antibody pembrolizumab in p (2020), LANCET ONCOLOGY, Marabelle A. | AcademicGPT, tlooto for Academic and Research